Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
- Study Title
- Open-Label Assessment of the Albuterol Spiromaxֲ® Dry Powder Inhaler (DPI)
- Teva Identifier
- ABS-AS-308
- ClinicalTrials.gov Identifier
- NCT01857323
- Study Status
- Completed
- Trial Condition(s)
- Asthma | Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: Albuterol Spiromaxֲ®
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 4 Years and older
- Trial Duration
- 05/01/2013 - 09/01/2013
- Phase
- Phase 3
